EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Controversy and multiple roles of the solitary nucleus receptor Nur77 in disease and physiology

Yanteng Wang iD, Na Li iD, Wenwei Guan iD, Difei Wang iD

The FASEB Journal · 2025

DOI: 10.1096/fj.202402775rr ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The FASEB Journal, 2025. Verfasst von Yanteng Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gerontology and Geriatrics, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China. Hauptthemen laut MEDLINE: Nuclear Receptor Subfamily 4, Group A, Member 1, Neurodegenerative Diseases, Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 181 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Department of Science and Technology of Liaoning Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuron‐derived clone 77 (Nur77), a member of the orphan nuclear receptor family, is expressed and activated rapidly in response to diverse physiological and pathological stimuli. It exerts complex biological functions, including roles in the nervous system, genome integrity, cell differentiation, homeostasis, oxidative stress, autophagy, aging, and infection. Recent studies suggest that Nur77 agonists alleviate symptoms of neurodegenerative diseases, highlighting its potential as a therapeutic target in such conditions. In cancer, Nur77 demonstrates dual roles, acting as both a tumor suppressor and promoter, depending on the cancer type and stage, making it a controversial yet promising anticancer target. This review provides a structured analysis of the functions of Nur77, focusing on its physiological and pathological roles, therapeutic potential, and existing controversies. Emphasis is placed on its emerging applications in neurodegenerative diseases and cancer, offering key insights for future research and clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nuclear Receptor Subfamily 4, Group A, Member 1Neurodegenerative DiseasesNeoplasmsHumansAnimalsAutophagyOxidative Stress

Stichwörter der Autor:innen

Nur77cancerneurodegenerationphysiological functiontranscription

Substanzen

Nuclear Receptor Subfamily 4, Group A, Member 1NR4A1 protein, human

Autor:innen und Institutionen

  • Department of Gerontology and Geriatrics, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.

ORCID-Profile: Yanteng Wang, Na Li, Wenwei Guan, Difei Wang

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • Department of Science and Technology of Liaoning Province
  • National Natural Science Foundation of China

Zitieren

APA

Wang, Y., Li, N., Guan, W., & Wang, D. (2025). Controversy and multiple roles of the solitary nucleus receptor Nur77 in disease and physiology. The FASEB Journal. https://doi.org/10.1096/fj.202402775rr

Vancouver

Wang Y, Li N, Guan W, Wang D. Controversy and multiple roles of the solitary nucleus receptor Nur77 in disease and physiology. The FASEB Journal. 2025. doi:10.1096/fj.202402775rr

BibTeX
@article{Wang2025,
  author = {Wang, Yanteng and Li, Na and Guan, Wenwei and Wang, Difei},
  title = {Controversy and multiple roles of the solitary nucleus receptor Nur77 in disease and physiology},
  journal = {The FASEB Journal},
  year = {2025},
  doi = {10.1096/fj.202402775rr}
}
Kostenlos starten →